Home / Stocks / DXCM

DexCom (DXCM, Health Care Equipment) Stock Valuation & Fair Value Significantly overvalued

DexCom (DXCM, Health Care Equipment) trades at a blended P/E of 36.7, about 69% below its historical normal valuation, with a forward growth estimate of 18.9% and a PEG of 1.94. Analysts' one-year estimates have been hit 27% of the time.

DATA AS OF 2026-08-21
Blended P/E
36.7
Normal P/E
116.5
PEG
1.94
Fwd growth
18.9%
Div yield
0.0%
RSI (14)
66.1
Neutral

The Street vs SeerForecast

Wall Street's mean price target for DXCM is $94.12 across 25 analysts, 1.9% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to significantly overvalued (2026-08-21).

Price and rating by weekClose moved +23.3 percent from 2026-06-03 to 2026-08-17, with 5 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 72.77 (recalculated)2026-06-10: Fairly valued, close 74.77 (recalculated)2026-06-14: Fairly valued, close 75.37 (recalculated)2026-06-16: Fairly valued, close 73.16 (recalculated)2026-06-21: Fairly valued, close 72.47 (recalculated)2026-07-02: Fairly valued, close 71.25 (recalculated)2026-07-06: Fairly valued, close 72.38 (recalculated)2026-07-09: Fairly valued, close 73.02 (recalculated)2026-07-12: Trading above fair value, close 74.96 (recalculated)2026-07-13: Trading above fair value, close 76.35 (recalculated)2026-07-14: Trading above fair value, close 74.12 (recalculated)2026-07-20: Trading above fair value, close 75.69 (recalculated)2026-07-22: Trading above fair value, close 71.43 (recalculated)2026-07-25: Fairly valued, close 71.54 (recalculated)2026-07-27: Fairly valued, close 73.37 (recalculated)2026-07-31: Trading above fair value, close 83.45 (recalculated)2026-08-03: Trading above fair value, close 83.452026-08-07: Trading above fair value, close 84.75 (recalculated)2026-08-10: Trading above fair value, close 84.752026-08-14: Significantly overvalued, close 89.75 (recalculated)2026-08-17: Trading above fair value, close 89.7573902026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 31.5-73%Fairly valued
2026-06-10P/E 31.6-73%Fairly valued
2026-06-14P/E 31.6-73%Fairly valued
2026-06-16P/E 31.6-73%Fairly valued
2026-06-21P/E 31.6-73%Fairly valued
2026-07-02P/E 29.4-75%Fairly valued
2026-07-06P/E 30.4-74%Fairly valued
2026-07-09P/E 30.4-74%Fairly valued
2026-07-12P/E 31.8-73%Trading above fair value
2026-07-13P/E 31.8-73%Trading above fair value
2026-07-14P/E 31.8-73%Trading above fair value
2026-07-20P/E 32.4-72%Trading above fair value
2026-07-22P/E 32.4-72%Trading above fair value
2026-07-25P/E 30.1-74%Fairly valued
2026-07-27P/E 30.1-74%Fairly valued
2026-07-31P/E 30.9-74%Trading above fair value
2026-08-03P/E 34.5-70%Trading above fair value
2026-08-07P/E 34.1-71%Trading above fair value
2026-08-10P/E 34.8-70%Trading above fair value
2026-08-14P/E 37.4-68%Significantly overvalued
2026-08-17P/E 36.6-69%Trading above fair value
2026-08-21P/E 36.7-69%Significantly overvalued ← now

Frequently asked questions

Is DexCom stock overvalued?

At a blended P/E of 36.7 versus its historical normal P/E of 116.5, DexCom trades about 69% below its typical valuation, with a PEG of 1.94 on 18.9% forward growth. tickerseer currently rates it significantly overvalued.

What is DexCom's fair value and PEG?

DexCom trades at a blended P/E of 36.7 against a historical normal P/E of 116.5, a PEG of 1.94, and a forward growth estimate of 18.9%.

Has tickerseer's rating of DexCom changed?

tickerseer's rating moved from fairly valued (2026-06-03) to significantly overvalued (2026-08-21).

What is the analyst price target for DexCom?

The mean Wall Street price target for DexCom is $94.12 across 25 analysts, 1.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track DXCM free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.